AIDS · 2010 · 167 citations · 31 references
Our results show a high prevalence of and considerable progression to osteopenia/osteoporosis in our cohort. Our findings support the importance of applying adequate strategies to prevent bone demineralization and of close monitoring of BMD in HIV-infected patients, specifically in at-risk patients who are taking antiretrovirals that affect bone mineralization.
31
CD4+ Count–Guided Interruption of Antiretroviral Treatment
New England Journal of Medicine · 2006 · 2.2K citations · Full text
Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy
Pablo Tebas, William G. Powderly, Sherry Claxton et al. · AIDS · 2000 · 541 citations